Semax 10mg Analytical Research Material

Semax

Synthetic ACTH-derived research peptide for neurotrophic, neuroplasticity, and central signaling investigation

Semax is a synthetic heptapeptide investigated in laboratory and preclinical research involving neurotrophic signaling, neuroplasticity, central nervous system pathways, gene-expression responses, and neuronal stress models.

Semax is structurally derived from the ACTH(4–7) peptide fragment with an added Pro-Gly-Pro sequence, producing the seven-amino-acid sequence Met-Glu-His-Phe-Pro-Gly-Pro.

Unlike compounds studied primarily through metabolic, incretin, or peripheral signaling pathways, Semax research focuses largely on central nervous system biology, neurotrophic-factor signaling, neuronal adaptation, and molecular responses to neurological stress.

Its distinct structure and research profile have made Semax relevant to experimental investigation involving BDNF-associated signaling, neuroplasticity, monoaminergic pathways, and neuronal gene-expression changes.

What is Semax?

Semax is a synthetic ACTH-derived research peptide based on the amino-acid sequence of adrenocorticotropic hormone residues 4 through 7.

Its structure is commonly described as:

ACTH(4–7)-Pro-Gly-Pro

or:

Met-Glu-His-Phe-Pro-Gly-Pro

The addition of the Pro-Gly-Pro (PGP) sequence differentiates Semax from the native ACTH fragment and has contributed to research into its stability and biological signaling profile.

Although Semax originates structurally from a fragment of ACTH, it is primarily studied for central neurological and molecular signaling characteristics rather than the classical endocrine activity associated with full-length ACTH.

Semax research commonly examines:

• Neurotrophic signaling

• BDNF-associated pathways

• Neuroplasticity

• Central nervous system signaling

• Neuronal gene expression

• Neuronal stress-response pathways

• Monoaminergic signaling

• Dopaminergic pathway research

• Serotonergic pathway research

• Neuroprotection-related experimental models

• Ischemia and neurological stress models

• Peptide-mediated neuronal signaling

Why is Semax researched?

A major area of scientific interest surrounding Semax is its relationship with neurotrophic and neuroplasticity-associated signaling.

Experimental research has examined Semax in connection with brain-derived neurotrophic factor (BDNF) and other molecular systems involved in neuronal signaling, adaptation, and gene-expression responses.

BDNF is widely studied because it participates in processes involving neuronal development, synaptic signaling, cellular adaptation, and neuroplasticity.

Semax has also been investigated in experimental models examining changes in monoaminergic neurotransmitter systems, including signaling associated with dopamine and serotonin.

Additional preclinical research has explored Semax in models involving neuronal stress, cerebral ischemia, inflammatory signaling, oxidative stress, and adaptive molecular responses within nervous tissue.

These research areas make Semax useful for investigating how a relatively small synthetic peptide may influence multiple components of central nervous system signaling and neuronal molecular biology.

In simple terms, researchers study Semax to better understand how peptide signaling may interact with neurotrophic factors, neuronal adaptation, neurotransmitter-associated pathways, and cellular responses to neurological stress.

What makes Semax different?

Semax has a research profile that differs substantially from peptides centered around metabolic or endocrine receptor systems.

ACTH-derived structure

Semax is based on the ACTH(4–7) fragment and incorporates a Pro-Gly-Pro extension, giving it a defined seven-amino-acid structure.

Neurotrophic-factor research

Semax has been investigated in connection with BDNF and other neurotrophic signaling pathways relevant to neuronal adaptation and plasticity.

Neuroplasticity-associated signaling

Researchers examine Semax in experimental models involving changes in neuronal signaling, synaptic adaptation, and gene-expression patterns.

Monoaminergic pathways

Preclinical research has explored relationships between Semax and dopaminergic, serotonergic, and other central neurotransmitter-associated systems.

Neuronal stress models

Semax has also been investigated in models involving ischemic stress, oxidative signaling, inflammatory responses, and neuronal cellular adaptation.

ACTH-derived structure. Neurotrophic signaling. Distinct central nervous system research profile.

What makes the TPG standard different?

We don’t rely on supplier paperwork alone.

Every TPG batch is built around independent analytical verification, lot-level traceability, and accessible testing documentation.

Where applicable to the analytical methods performed, independent laboratory testing evaluates whether the tested material matches its stated identity, quantity, and purity specifications.

Semax

✓ Batch-specific identification
✓ Quantitative content analysis
✓ Chromatographic purity analysis where performed
✓ Independent third-party laboratory testing
✓ Lot-specific documentation
✓ Certificate of Analysis availability
✓ Cold stored and carefully shipped

The Peptide Group Standard

Supplier documentation tells you what a material is claimed to contain.

Independent analytical testing determines whether the tested sample matches those stated specifications.

That distinction is central to the TPG standard.

We focus on identifiable lots, independent analytical data, and documentation researchers can review rather than relying solely on manufacturer or supplier claims.

Our standard is straightforward:

Identity. Quantity. Purity. Traceability.

Clearly identified material backed by analytical documentation.

Research first. Receipts included.

Product Information

Semax is supplied as a single vial of analytical research material.

Lot-specific documentation and Certificate of Analysis information may be provided for applicable batches to support laboratory recordkeeping, material identification, analytical review, and batch traceability.

Specifications

• Compound: Semax

• Structural designation: ACTH(4–7)-Pro-Gly-Pro

• Sequence: Met-Glu-His-Phe-Pro-Gly-Pro

• Compound class: Synthetic ACTH-derived research peptide

• Primary research areas: Neurotrophic signaling, BDNF-associated pathways, neuroplasticity, central nervous system signaling, neuronal stress-response pathways

• Analytical research material

• Batch-specific identification

• Independent third-party analytical testing

• Certificate of Analysis where applicable

• Lot-level traceability

• Cold stored and carefully shipped

Research Use Notice

For analytical and laboratory research purposes only.

Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.

Manufacturer and supplier information may be redacted from publicly displayed certificates to protect proprietary sourcing information and prevent unauthorized duplication or reuse. Analytical results, purity data, tested content, and reported quantities are not altered by these redactions.